Skip to main content
. 2021 Feb 10;14:589–600. doi: 10.2147/DMSO.S287281

Table 3.

The Distribution of MetS Among the Participants Stratified by Sex (n=266)

Variables Categories Metabolic Syndrome
Overall (%) 58 (21.8%)) Men (%) 23 (18.5%) Women (%) 35(24.6%) p-value (X2) 0.229
Age 20–39 19 (11.3) 8 (10.8) 11 (11.7) 0.790
≥40 39 (39.8) 15 (30.0) 24 (50.0)
Monthly income (ranked) Low 9 (8.8) 1 (1.9) 8 (16.7) 0.018*
Medium 21 (25.3) 13 (30.2) 8 (20.0)
High 28 (34.6) 9 (33.3) 19 (35.2)
Fasting blood glucose Normal 26 (12.4) 8 (8.6) 18 (15.5) 0.255
Pre-diabetes 16 (45.7) 9 (47.4) 7 (43.8)
Diabetes 16 (72.7) 6 (50.0) 10 (100.0)
Triglyceride <150 9 (5.5) 2 (3.1) 7 (7.0) 0.220
150–199 14 (35.9) 4 (20.0) 10 (52.6)
≥200 35 (56.5) 17 (43.6) 18 (78.3)
Total cholesterol <200 26 (13.9) 11 (12.4) 15 (15.3) 0.929
200–239 19 (40.4) 7 (31.8) 12 (48.0)
≥240 13 (40.6) 5 (38.5) 8 (42.1)
HDL-C (M/W) ≥40/50 38 (16.7) 114(91.9) 114(80.3) 0.098
<40/50 20 (52.6) 10 (8.1) 28 (19.7)
LDL-C <130 14 (10.6) 5 (7.7) 9 (13.4) 0.904
130–159 13 (28.9) 5 (25.0) 8 (32.0)
160–189 10 (25.6) 5 (27.8) 5 (23.8)
≥190 21 (42.0) 8 (38.1) 13 (44.8)
Systolic blood pressure <130 mmHg 16 (9.1) 8 (9.8) 8 (8.5) 0.320
≥130 mmHg 42 (46.7) 15 (35.7) 27 (56.3)
Diastolic blood pressure <85 mmHg 19 (10.6) 6 (7.4) 13 (13.3) 0.380
≥85 mmHg 39 (44.8) 17 (39.5) 22 (50.0)
Body mass index Underweight 0 (0.0) 0 (0.0) 0 (0.0) 0.044*
Normal 16 (10.7) 5 (6.9) 11 (14.1)
Overweight 24 (38.1) 14 (41.2) 10 (34.5)
Obese 18 (66.7) 4 (50.0) 14 (73.7)
WC (cm) (M/W) <94/80 0 (0.0) 0 (0.0) 0 (0.0) NA
≥94/80 58 (52.3) 23 (71.9) 35 (44.3)
W-Ht-R (M/W) <0.49/0.50 0 (0.0) 0 (0.0) 0 (0.0) 0.901
≥0.49/0.50 58 (36.7) 23 (31.5) 35 (41.2)
W-Hip-R (M/W) <0.88/0.82 2 (2.5) 1 (2.2) 1 (2.9) 0.039*
≥0.88/0.82 56 (30.1) 22 (27.8) 34 (31.8)

Note: *Significant difference.

Abbreviations: HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; M/W, men/women; SD, standard deviation; WC, waist circumference; W-Ht-R, waist to height ratio; W-Hip-R, waist to hip ratio.